DYSIS Medical, Inc.
DYSIS Medical, Inc., headquartered in the United States, is a pioneering company in the medical technology industry, specialising in advanced diagnostic solutions for cervical cancer screening. Founded in 2010, DYSIS has made significant strides in enhancing patient care through its innovative products, notably the DYSIS Colposcope, which integrates advanced imaging and analytics to improve clinical outcomes. With a strong presence in North America and Europe, DYSIS Medical is recognised for its commitment to precision and efficiency in gynaecological diagnostics. The company’s unique approach combines cutting-edge technology with user-friendly interfaces, setting it apart in a competitive market. DYSIS Medical continues to solidify its position as a leader in cervical health, contributing to early detection and better management of cervical cancer.
DitchCarbon Score
How does DYSIS Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
DYSIS Medical, Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
DYSIS Medical, Inc.'s reported carbon emissions
DYSIS Medical, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or climate commitments. Without specific emissions figures or defined initiatives, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the medical device industry. As the focus on sustainability intensifies, it is essential for companies like DYSIS Medical to establish clear climate commitments and reduction strategies to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
DYSIS Medical, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
